2023 Vol.41, N°5 - Table of contents
May 2023
Editorial
CER14842
2023,41,5
Pg. 0993-0996
Free to view
Telemedicine for rheumatological consultation: the new semeiotics for rheumatic examination
F.R. Spinelli, M. Govoni, F. Iannone, M. Mosca, A. Cauli, B. Frediani, R. Caporali, F. Conti
DOI: https://doi.org/10.55563/clinexprheumatol/eeexhg
F.R. Spinelli, M. Govoni, F. Iannone, M. Mosca, A. Cauli, B. Frediani, R. Caporali, F. Conti
DOI: https://doi.org/10.55563/clinexprheumatol/eeexhg
One year in review
CER16623
2023,41,5
Pg. 0997-1008
Free to view
Systemic lupus erythematosus: one year in review 2023
D. Zucchi, E. Silvagni, E. Elefante, V. Signorini, C. Cardelli, F. Trentin, D. Schilirò, G. Cascarano, A. Valevich, A. Bortoluzzi, C. Tani
DOI: https://doi.org/10.55563/clinexprheumatol/4uc7e8
D. Zucchi, E. Silvagni, E. Elefante, V. Signorini, C. Cardelli, F. Trentin, D. Schilirò, G. Cascarano, A. Valevich, A. Bortoluzzi, C. Tani
DOI: https://doi.org/10.55563/clinexprheumatol/4uc7e8
Full Papers
CER15570
2023,41,5
Pg. 1009-1016
Towards a universal definition of disease activity score thresholds: the AS135 score
N. Foulquier, B. Chevet, G. Carvajal Alegria, L. Saraux, V. Devauchelle-Pensec, P. Redou, A. Saraux
DOI: https://doi.org/10.55563/clinexprheumatol/30qjog
N. Foulquier, B. Chevet, G. Carvajal Alegria, L. Saraux, V. Devauchelle-Pensec, P. Redou, A. Saraux
DOI: https://doi.org/10.55563/clinexprheumatol/30qjog
CER15832
2023,41,5
Pg. 1017-1023
Free to view
Early recognition of catastrophic antiphospholipid syndrome in patients with antiphospholipid syndrome based on a Chinese cohort study
C. Huang, Y. Zhao, X. Tian, Q. Wang, C. Hu, N. Jiang, S. Zhou, L. Zhang, J. Zhou, C. Wu, J. Li, D. Wu, J. Zhao, M. Li, X. Zeng
DOI: https://doi.org/10.55563/clinexprheumatol/e0voi7
C. Huang, Y. Zhao, X. Tian, Q. Wang, C. Hu, N. Jiang, S. Zhou, L. Zhang, J. Zhou, C. Wu, J. Li, D. Wu, J. Zhao, M. Li, X. Zeng
DOI: https://doi.org/10.55563/clinexprheumatol/e0voi7
CER15824
2023,41,5
Pg. 1024-1033
Free to view
Incidence of autoantibodies related to systemic autoimmunity in patients with severe COVID-19 admitted to the intensive care unit
K. Bitzogli, E. Jahaj, A.-D. Bakasis, E.K. Kapsogeorgou, A.V. Goules, I. Stergiou, V. Pezoulas, C. Antoniadou, P. Skendros, K. Ritis, D.I. Fotiadis, A. Kotanidou, A.G. Tzioufas, P.G. Vlachoyiannopoulos
DOI: https://doi.org/10.55563/clinexprheumatol/2remcx
K. Bitzogli, E. Jahaj, A.-D. Bakasis, E.K. Kapsogeorgou, A.V. Goules, I. Stergiou, V. Pezoulas, C. Antoniadou, P. Skendros, K. Ritis, D.I. Fotiadis, A. Kotanidou, A.G. Tzioufas, P.G. Vlachoyiannopoulos
DOI: https://doi.org/10.55563/clinexprheumatol/2remcx
CER15698
2023,41,5
Pg. 1034-1041
Free to view
Efficacy and drug retention of tofacitinib in rheumatoid arthritis: from the nationwide Korean College of Rheumatology Biologics registry
J.-Y. Jung, E. Lee, J.-W. Kim, C.-H. Suh, H.-A. Kim
DOI: https://doi.org/10.55563/clinexprheumatol/6fcyza
J.-Y. Jung, E. Lee, J.-W. Kim, C.-H. Suh, H.-A. Kim
DOI: https://doi.org/10.55563/clinexprheumatol/6fcyza
CER15747
2023,41,5
Pg. 1042-1049
Improvements in work productivity among patients with inflammatory arthritis and osteoarthritis in the first six months after diagnosis: an inception cohort study
L. Xiang, A.H.L. Low, Y.-Y. Leung, W. Fong, W.-H. Gan, N. Graves, M. Gandhi, J. Thumboo
DOI: https://doi.org/10.55563/clinexprheumatol/n25nd7
L. Xiang, A.H.L. Low, Y.-Y. Leung, W. Fong, W.-H. Gan, N. Graves, M. Gandhi, J. Thumboo
DOI: https://doi.org/10.55563/clinexprheumatol/n25nd7
CER15781
2023,41,5
Pg. 1050-1058
Free to view
Clinical and ultrasonographic evaluation of the window of opportunity for retreatment with rituximab in rheumatoid arthritis patients from a multicentre real-life study
O. Vittecoq, M. Kozyreff-Meurice, E. Houivet, N. Leon, L. Berard, M. Gauthier-Prieur, S. Pouplin, G. Avenel, P. Brevet, J. Benichou, P. Michelin, C. Marcelli, T. Lequerre
DOI: https://doi.org/10.55563/clinexprheumatol/zf8nnm
O. Vittecoq, M. Kozyreff-Meurice, E. Houivet, N. Leon, L. Berard, M. Gauthier-Prieur, S. Pouplin, G. Avenel, P. Brevet, J. Benichou, P. Michelin, C. Marcelli, T. Lequerre
DOI: https://doi.org/10.55563/clinexprheumatol/zf8nnm
CER15721
2023,41,5
Pg. 1059-1067
Free to view
The frequency of synovitis and calcium pyrophosphate deposition with ultrasound is increased in transfusion-dependent beta-thalassaemia patients: effect of iron accumulation?
S. Ermurat, E. Güler Kazancı, K. Ayar, V. Gürsoy
DOI: https://doi.org/10.55563/clinexprheumatol/dzc7ef
S. Ermurat, E. Güler Kazancı, K. Ayar, V. Gürsoy
DOI: https://doi.org/10.55563/clinexprheumatol/dzc7ef
CER15789
2023,41,5
Pg. 1068-1076
Identification of a circRNA-miRNA-mRNA network to explore the effects of circRNAs on pathogenesis and treatment of systemic lupus erythematosus
Q. Wei, J. He, C. Wu, P. Makota, F. Gao, H. Lin, L. Cai, Z. Chen
DOI: https://doi.org/10.55563/clinexprheumatol/kgm1rn
Q. Wei, J. He, C. Wu, P. Makota, F. Gao, H. Lin, L. Cai, Z. Chen
DOI: https://doi.org/10.55563/clinexprheumatol/kgm1rn
CER15790
2023,41,5
Pg. 1077-1087
Free to view
Effect of Janus kinase inhibitors on T cell responses to herpes zoster in rheumatoid arthritis patients
J.-Y. Lee, S.H. Kim, S.-H. Lee, H.-R. Kim, H.K. Min
DOI: https://doi.org/10.55563/clinexprheumatol/xzgaoy
J.-Y. Lee, S.H. Kim, S.-H. Lee, H.-R. Kim, H.K. Min
DOI: https://doi.org/10.55563/clinexprheumatol/xzgaoy
CER15707
2023,41,5
Pg. 1088-1095
Free to view
Persistence of remission after lengthening of golimumab in inflammatory joint diseases
A. Damiani, F. Bartoli, G. Pacini, D. Carboni, S. Bellando Randone, G. Fiori, M. Matucci-Cerinic, S. Guiducci
DOI: https://doi.org/10.55563/clinexprheumatol/k76z51
A. Damiani, F. Bartoli, G. Pacini, D. Carboni, S. Bellando Randone, G. Fiori, M. Matucci-Cerinic, S. Guiducci
DOI: https://doi.org/10.55563/clinexprheumatol/k76z51
CER15844
2023,41,5
Pg. 1096-1104
Free to view
The faecal microbiota is distinct in HLA-B27+ ankylosing spondylitis patients versus HLA-B27+ healthy controls
M.L. Stoll, H. Sawhney, P.M. Wells, P.R. Sternes, J.D. Reveille, C.D. Morrow, C.J. Steves, M.A. Brown, L.S. Gensler
DOI: https://doi.org/10.55563/clinexprheumatol/nlsj0o
M.L. Stoll, H. Sawhney, P.M. Wells, P.R. Sternes, J.D. Reveille, C.D. Morrow, C.J. Steves, M.A. Brown, L.S. Gensler
DOI: https://doi.org/10.55563/clinexprheumatol/nlsj0o
CER15869
2023,41,5
Pg. 1105-1113
A link between CD8+CD27-CD28- T cells expressing chemerin chemokine-like receptor 1 and rheumatoid arthritis
E. Jeong, J.-Y. Jung, M.J. Lee, H.-A. Kim, H.Y. Yang, K. Kim, S. Park
DOI: https://doi.org/10.55563/clinexprheumatol/52v1bb
E. Jeong, J.-Y. Jung, M.J. Lee, H.-A. Kim, H.Y. Yang, K. Kim, S. Park
DOI: https://doi.org/10.55563/clinexprheumatol/52v1bb
CER15865
2023,41,5
Pg. 1114-1119
Free to view
A paradigm of difficult-to-treat rheumatoid arthritis: subtypes and early identification
M. Novella-Navarro, V. Ruiz-Esquide, G. Torres-Ortiz, C.A. Chacur, C. Tornero, E. Fernández-Fernández, I. Monjo, R. Sanmartí, C. Plasencia-Rodríguez, A. Balsa
DOI: https://doi.org/10.55563/clinexprheumatol/7mscci
M. Novella-Navarro, V. Ruiz-Esquide, G. Torres-Ortiz, C.A. Chacur, C. Tornero, E. Fernández-Fernández, I. Monjo, R. Sanmartí, C. Plasencia-Rodríguez, A. Balsa
DOI: https://doi.org/10.55563/clinexprheumatol/7mscci
CER15911
2023,41,5
Pg. 1120-1128
Free to view
Lipid metabolomic signature might predict subclinical atherosclerosis in patients with active rheumatoid arthritis
C.-K. Chang, K.-H. Chang, W.-C. Cheng, P.-K. Chen, E.-P. Chiang, S.-H. Chang, Y.-C. Li, C.-H. Chen, D.-Y. Chen
DOI: https://doi.org/10.55563/clinexprheumatol/int08c
C.-K. Chang, K.-H. Chang, W.-C. Cheng, P.-K. Chen, E.-P. Chiang, S.-H. Chang, Y.-C. Li, C.-H. Chen, D.-Y. Chen
DOI: https://doi.org/10.55563/clinexprheumatol/int08c
CER15437
2023,41,5
Pg. 1129-1139
Free to view
Haemoglobin changes and disease activity in Japanese patients with rheumatoid arthritis treated with sarilumab
Y. Tanaka, T. Takahashi, H. Van Hoogstraten, A. Praestgaard, N. Kato, H. Kameda
DOI: https://doi.org/10.55563/clinexprheumatol/jq9u8f
Y. Tanaka, T. Takahashi, H. Van Hoogstraten, A. Praestgaard, N. Kato, H. Kameda
DOI: https://doi.org/10.55563/clinexprheumatol/jq9u8f
CER16028
2023,41,5
Pg. 1140-1148
Free to view
Progression and prognosis of interstitial pneumonia with autoimmune features: a longitudinal, prospective, multi-centre study
G. Sambataro, D. Sambataro, L. Spicuzza, F. Meloni, G. Lorini, L. Malatino, M. Colaci, G. Sebastiani, A. Iuliano, C. Canofari, F. Luppi, G. Franco, U. Zanini, A. Manfredi, F. Gozzi, M. Sebastiani, S. Palmucci, L. Cavagna, C. Vancheri
DOI: https://doi.org/10.55563/clinexprheumatol/lycdca
G. Sambataro, D. Sambataro, L. Spicuzza, F. Meloni, G. Lorini, L. Malatino, M. Colaci, G. Sebastiani, A. Iuliano, C. Canofari, F. Luppi, G. Franco, U. Zanini, A. Manfredi, F. Gozzi, M. Sebastiani, S. Palmucci, L. Cavagna, C. Vancheri
DOI: https://doi.org/10.55563/clinexprheumatol/lycdca
CER16029
2023,41,5
Pg. 1149-1154
Folate deficiency is associated with increased radiographic severity of osteoarthritis in knee joints but not in hand joints
H. Xu, M.-H. Shin, J.-H. Kang, S.-E. Choi, D.-J. Park, S.-S. Kweon, Y.-H. Lee, H.-Y. Kim, J.-K. Lee, S.-S. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/69k9xr
H. Xu, M.-H. Shin, J.-H. Kang, S.-E. Choi, D.-J. Park, S.-S. Kweon, Y.-H. Lee, H.-Y. Kim, J.-K. Lee, S.-S. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/69k9xr
CER15761
2023,41,5
Pg. 1155-1162
Urine soluble triggering receptor expressed on myeloid cells-1 is a novel biomarker for active lupus nephritis: a case-control study
Y. Molad, M. Egbaria, A. Tovar, A. Dortort Lazar, E. Pokroy Shapira, S. Oren, Y. Edel, V. Kliminski
DOI: https://doi.org/10.55563/clinexprheumatol/4lvaye
Y. Molad, M. Egbaria, A. Tovar, A. Dortort Lazar, E. Pokroy Shapira, S. Oren, Y. Edel, V. Kliminski
DOI: https://doi.org/10.55563/clinexprheumatol/4lvaye
CER16001
2023,41,5
Pg. 1163-1169
Equivalent cut-off values of Bath Ankylosing Spondylitis Disease Activity Index corresponding to Ankylosing Spondylitis Disease Activity Score cut-off values
R. Cui, Y. Du, N. Tian, H.-L. Jiang, Y.-L. Tao, S.-M. Dai
DOI: https://doi.org/10.55563/clinexprheumatol/2kjgx2
R. Cui, Y. Du, N. Tian, H.-L. Jiang, Y.-L. Tao, S.-M. Dai
DOI: https://doi.org/10.55563/clinexprheumatol/2kjgx2
CER15809
2023,41,5
Pg. 1170-1178
Serum soluble E-cadherin is a new potential marker for assessing the severity of gout
Q. Zhao, Y. Xiong, X. Man, Y. Liu, Y. Huang, W. Chen, B. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/cezkk0
Q. Zhao, Y. Xiong, X. Man, Y. Liu, Y. Huang, W. Chen, B. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/cezkk0
Brief Paper
CER16133
2023,41,5
Pg. 1179-1182
Free to view
HLA-Cw6 allele and biologic therapy are protective factors against liver fibrosis in psoriatic arthritis patients
C. Macía-Villa, J.L. Morell-Hita, M. Revenga-Martínez, C. Díaz-Miguel pérez
DOI: https://doi.org/10.55563/clinexprheumatol/anuuqb
C. Macía-Villa, J.L. Morell-Hita, M. Revenga-Martínez, C. Díaz-Miguel pérez
DOI: https://doi.org/10.55563/clinexprheumatol/anuuqb
Paediatric Rheumatology
CER15622
2023,41,5
Pg. 1183-1191
Free to view
High incidence of multisystem inflammatory syndrome and other autoimmune diseases after SARS-CoV-2 infection compared to COVID-19 vaccination in children and adolescents in south central Europe
M. Bizjak, N. Emeršič, M. Zajc Avramovič, F. Barbone, F. Ronchese, S. Della Paolera, E. Conversano, S. Amoroso, M. Vidoni, T. Vesel Tajnšek, G. Mlakar, V. Berce, G. Markelj, T. Plankar Srovin, T. Golli, D. Osredkar, A. Koren Jeverica, N. Toplak, M. Pokorn, T. Avšič Županc, A. Ihan, M. Fafangel, A. Taddio, T. Avčin
DOI: https://doi.org/10.55563/clinexprheumatol/i1l2xn
M. Bizjak, N. Emeršič, M. Zajc Avramovič, F. Barbone, F. Ronchese, S. Della Paolera, E. Conversano, S. Amoroso, M. Vidoni, T. Vesel Tajnšek, G. Mlakar, V. Berce, G. Markelj, T. Plankar Srovin, T. Golli, D. Osredkar, A. Koren Jeverica, N. Toplak, M. Pokorn, T. Avšič Županc, A. Ihan, M. Fafangel, A. Taddio, T. Avčin
DOI: https://doi.org/10.55563/clinexprheumatol/i1l2xn
CER15720
2023,41,5
Pg. 1192-1197
Use of psychotropic medication in incident juvenile idiopathic arthritis patients from 2000 to 2014: a case-control cohort study
M.S. Kyllönen, H. Kautiainen, E. Jääskeläinen, K. Puolakka, P. Vähäsalo
DOI: https://doi.org/10.55563/clinexprheumatol/26u6uu
M.S. Kyllönen, H. Kautiainen, E. Jääskeläinen, K. Puolakka, P. Vähäsalo
DOI: https://doi.org/10.55563/clinexprheumatol/26u6uu
Letters to the Editor
CER16367
2023,41,5
Pg. 1198-1199
Free to view
Association between increased serum IL-23 levels and ACPA positivity in patients with rheumatoid arthritis
H. Kohno, T. Sugimoto, Y. Yoshida, S. Mokuda, S. Hirata, E. Sugiyama
DOI: https://doi.org/10.55563/clinexprheumatol/1yfr4z
H. Kohno, T. Sugimoto, Y. Yoshida, S. Mokuda, S. Hirata, E. Sugiyama
DOI: https://doi.org/10.55563/clinexprheumatol/1yfr4z
CER16304
2023,41,5
Pg. 1200-1201
Free to view
Acid sphingomyelinase regulates the biological functions of fibroblast-like synoviocytes
Z. Luo, H. Liu, Y. Luo, Y. Chen
DOI: https://doi.org/10.55563/clinexprheumatol/7gyakm
Z. Luo, H. Liu, Y. Luo, Y. Chen
DOI: https://doi.org/10.55563/clinexprheumatol/7gyakm
CER16443
2023,41,5
Pg. 1202-1203
Free to view
Low Omicron BA.4 and BA.5 neutralising activity and breakthrough COVID-19 following pre-exposure prophylaxis with tixagevimab plus cilgavimab in vaccinated patients with autoimmune disease
C.M. Connolly, A.H. Karaba, T. Po-Yu chiang, M. Teles, J.D. Kim, T. Scott Johnson, J.L. Alejo, D.L. Segev, L. Christopher-Stine, W.A. Werbel, J.J. Paik
DOI: https://doi.org/10.55563/clinexprheumatol/pfli7o
C.M. Connolly, A.H. Karaba, T. Po-Yu chiang, M. Teles, J.D. Kim, T. Scott Johnson, J.L. Alejo, D.L. Segev, L. Christopher-Stine, W.A. Werbel, J.J. Paik
DOI: https://doi.org/10.55563/clinexprheumatol/pfli7o